Machine learning constructs an anaphase-promoting complex (ANAPC) related signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma
Kunwei Peng, Shousheng Liu, Haoqian Song, Cuirong Tan, Jiaxin Yang, Li Liao
Springer Nature ·
2026-11-21
· DOI 10.1186/s12885-026-17420-1
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Kunwei Peng, Shousheng Liu, Haoqian Song, Cuirong Tan, Jiaxin Yang, Li Liao. Machine learning constructs an anaphase-promoting complex (ANAPC) related signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma. // BMC Cancer. – 2026. – DOI: 10.1186/s12885-026-17420-1. – URL: https://doi.org/10.1186/s12885-026-17420-1
Kunwei Peng, Shousheng Liu, Haoqian Song, Cuirong Tan, Jiaxin Yang, & Li Liao (2026). Machine learning constructs an anaphase-promoting complex (ANAPC) related signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma. BMC Cancer. https://doi.org/10.1186/s12885-026-17420-1
Kunwei Peng, et al. “Machine learning constructs an anaphase-promoting complex (ANAPC) related signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma.” BMC Cancer, 2026. doi:10.1186/s12885-026-17420-1.
@article{Peng2026,
title = {Machine learning constructs an anaphase-promoting complex (ANAPC) related signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma},
author = {Peng, Kunwei and Liu, Shousheng and Song, Haoqian and Tan, Cuirong and Yang, Jiaxin and Liao, Li},
journal = {BMC Cancer},
year = {2026},
doi = {10.1186/s12885-026-17420-1},
url = {https://doi.org/10.1186/s12885-026-17420-1}
}